Tag: nominal
Neovacs: The nominal value of the share is reduced from 1 euro to 0.10 euro
HC Published on 04/03/2024 at 7:07 a.m. Photo credit © ChaunuPictures (Boursier.com) — Neovacs a…
NEOVACS: Adjustment of the nominal value – 04/02/2024 at 8:00 p.m.
Suresnes, April 2, 2024 – 8 p.m. CET – Néovacs (Euronext Growth Paris: ALNEV), a biopharmaceutical company at a preclinical stage developing new therapies for inflammatory and autoimmune diseases, announces…
PHARNEXT: Adjustment of the nominal value – 03/20/2024 at 7:30 p.m.
PARIS, France, March 20, 2024 at 7:00 p.m. (CET) – Pharnext SCA (FR001400N1P4 – ALPHA) (the “Company”), an advanced clinical stage biopharmaceutical company developing new therapies for neurodegenerative diseases without…
PHARNEXT: Adjustment of the nominal value – 02/20/2024 at 6:00 p.m.
PARIS, France, February 20, 2024 at 6:00 p.m. (CET) – Pharnext SCA (FR001400N1P4 – ALPHA) (the “Company”), an advanced clinical stage biopharmaceutical company developing new therapies for neurodegenerative diseases without…
Hoffmann Green announces the completion of an issue of bonds with the option of conversion and/or exchange into new or existing shares for a nominal amount of approximately 5 million euros subscribed by Eiffel Investment Group – 02/16/2024 at 9:00 p.m.
Chaillé-sous-les-Ormeaux, February 16, 2024 – 9:00 p.m. CET: Hoffmann Green Cement Technologies (ISIN: FR0013451044 / ticker: ALHGR) (“Hoffmann Green Cement” or the “Company”), an industrial player committed to the decarbonization…
BOOSTHEAT: ADJUSTMENT OF THE NOMINAL VALUE – 02/09/2024 at 10:30 p.m.
Vénissieux, February 9, 2024 BOOSTHEAT (FR001400IAM7 / ALBOO), a French industrial and software player in energy efficiency, announces an adjustment to the nominal value of the Company’s shares. The Board…
Neovacs multiplies the nominal value of its shares by 10,000
(AOF) – Neovacs announces that it has decided to implement a consolidation of the shares making up its share capital, at the rate of 1 new share against 10,000 old…
Pharnext divides the nominal value of its shares by ten
(AOF) – Pharnext announces today that the management of the company, on the basis of the 7th resolution voted at the General Meeting of June 30, 2023, has decided to…
PHARNEXT: Adjustment of the nominal value – 11/13/2023 at 08:30
PARIS, France, November 13, 2023 at 8:30 a.m. (CET) – Pharnext SCA (FR001400JXB0 – ALPHA) (the “Company”), an advanced clinical stage biopharmaceutical company developing new therapies for neurodegenerative diseases without…
PHARNEXT: Adjustment of the nominal value – 10/24/2023 at 9:00 p.m.
PARIS, France, October 24, 2023 at 9 p.m. (CET) – Pharnext SA (FR001400JXB0 – ALPHA) (the “Company”), an advanced clinical stage biopharmaceutical company developing new therapies for neurodegenerative diseases without…
NEOVACS: Adjustment of the nominal value – 02/10/2023 at 22:00
Suresnes, October 2, 2023 – 10:00 p.m. CET – The Board of Directors of NEOVACS (Euronext Growth Paris: ALNEV), on the basis of the 8 th resolution voted at the…
PHARNEXT: Adjustment of the nominal value – 09/29/2023 at 7:00 p.m.
PARIS, France, September 29, 2023 at 7 p.m. (CET) – Pharnext SA (FR001400JXB0 – ALPHA) (the “Company”), an advanced clinical stage biopharmaceutical company developing new therapies for neurodegenerative diseases without…